Literature DB >> 12774942

Electro-gene-transfer: a new approach for muscle gene delivery.

Elena Fattori1, Nicola La Monica, Gennaro Ciliberto, Carlo Toniatti.   

Abstract

Gene transfer into skeletal muscle cells by direct injection of naked plasmid DNA results in sustained gene expression. Intramuscular injection of plasmid DNA might thus be used to correct myopathies, to secrete locally or systematic therapeutic proteins and to elicit an immune response against specific antigens. However, the potential utility of this technique for gene application in humans is limited by the poor transduction efficiency and the low and highly variable level of gene expression. Different methods are thus being developed to increase the efficiency of gene transfer in muscles. It has been recently reported that a dramatic improvement of DNA transfer is achieved by applying an electric field to the muscle fibers subsequent to local DNA injection. Electro-gene-transfer increases gene expression by several orders of magnitude and strongly reduces interindividual variability. Electroinjection of genes encoding for secreted proteins resulted in sustained expression and disease correction in animal models of gene therapy. Moreover, the immunogenicity of DNA vaccines is dramatically increased when antigen-encoding plasmids are delivered by this technique. This technique may thus have broad and important applications in human gene therapy. This review provides a brief overview of the theory of electro-gene-transfer and describes parameters governing its efficiency in muscle. We also summarize the results obtained with electro-gene-transfer in animal models to date and the technical issues that must be solved before its use for human therapy can be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12774942     DOI: 10.1023/a:1022927822244

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  11 in total

1.  Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA.

Authors:  Oranuch Thanaketpaisarn; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

2.  Inhibition of myostatin gene expression in skeletal muscle of fish by in vivo electrically mediated dsRNA and shRNAi delivery.

Authors:  Genciana Terova; Simona Rimoldi; Giovanni Bernardini; Marco Saroglia
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 3.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

4.  Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.

Authors:  C A Fernandez; N J Baumhover; J T Duskey; S Khargharia; K Kizzire; M D Ericson; K G Rice
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

5.  Innovation and translation efforts in wireless medical connectivity, telemedicine and eMedicine: a story from the RFID Center of Excellence at the University of Pittsburgh.

Authors:  Ervin Sejdić; Michael A Rothfuss; Joshua R Stachel; Nicholas G Franconi; Kara Bocan; Michael R Lovell; Marlin H Mickle
Journal:  Ann Biomed Eng       Date:  2013-07-30       Impact factor: 3.934

6.  Evaluation of a novel non-penetrating electrode for use in DNA vaccination.

Authors:  Amy Donate; Domenico Coppola; Yolmari Cruz; Richard Heller
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Efficient expression of transgenes in adult zebrafish by electroporation.

Authors:  K Murali Rambabu; S Hari Narayana Rao; N Madhusudhana Rao
Journal:  BMC Biotechnol       Date:  2005-10-13       Impact factor: 2.563

8.  COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

Authors:  Antonella Conforti; Emanuele Marra; Fabio Palombo; Giuseppe Roscilli; Micol Ravà; Valeria Fumagalli; Alessia Muzi; Mariano Maffei; Laura Luberto; Lucia Lione; Erika Salvatori; Mirco Compagnone; Eleonora Pinto; Emiliano Pavoni; Federica Bucci; Grazia Vitagliano; Daniela Stoppoloni; Maria Lucrezia Pacello; Manuela Cappelletti; Fabiana Fosca Ferrara; Emanuela D'Acunto; Valerio Chiarini; Roberto Arriga; Abraham Nyska; Pietro Di Lucia; Davide Marotta; Elisa Bono; Leonardo Giustini; Eleonora Sala; Chiara Perucchini; Jemma Paterson; Kathryn Ann Ryan; Amy-Rose Challis; Giulia Matusali; Francesca Colavita; Gianfranco Caselli; Elena Criscuolo; Nicola Clementi; Nicasio Mancini; Rüdiger Groß; Alina Seidel; Lukas Wettstein; Jan Münch; Lorena Donnici; Matteo Conti; Raffaele De Francesco; Mirela Kuka; Gennaro Ciliberto; Concetta Castilletti; Maria Rosaria Capobianchi; Giuseppe Ippolito; Luca G Guidotti; Lucio Rovati; Matteo Iannacone; Luigi Aurisicchio
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

9.  Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.

Authors:  Claudia Marcela Diaz; Alberto Chiappori; Luigi Aurisicchio; Ansuman Bagchi; Jason Clark; Sheri Dubey; Arthur Fridman; Jesus C Fabregas; John Marshall; Elisa Scarselli; Nicola La Monica; Gennaro Ciliberto; Alberto J Montero
Journal:  J Transl Med       Date:  2013-03-08       Impact factor: 5.531

10.  Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.

Authors:  Urska Kamensek; Gregor Sersa; Maja Cemazar
Journal:  Mol Cancer       Date:  2013-11-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.